Last reviewed · How we verify
NCT06597773
Online Patient Navigation Program for Patients With Breast Cancer
NA trial testing Online patient navigation and supportive care referrals in Breast Cancer. Withdrawn.
22 September 2025
Quick facts
| Lead sponsor | Medicos e Investigadores en la Lucha contra el Cancer de Mama |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Start date | 21 September 2025 |
| Primary completion | 22 September 2025 |
| Estimated completion | 23 September 2025 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Online patient navigation and supportive care referrals
- In-person patient navigation and supportive care referrals
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Supportive Care in Cancer — all drugs for Supportive Care in Cancer →
- Patient Navigation — all drugs for Patient Navigation →
Sponsor
Medicos e Investigadores en la Lucha contra el Cancer de Mama
Who can join
18 and older, female only, with Breast Cancer or Supportive Care in Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this prospective 1:1 randomized controlled trial is to evaluate if an online patient navigation program, designed to identify targeted supportive care needs and to facilitate referrals and web-based interventions to address these needs, can increase patients' access to supportive care services, compared to traditional in-person patient navigation providing referrals to in-person supportive care services. The main questions it aims to answer are: * Does online patient navigation increase access to supportive care services among patients with breast cancer? * Which are the barriers that hinder patients' access to the supportive care services they require? * What is patients' level of satisfaction with online patient navigation? Participants will: * Participate in an online or in-person patient navigation program for 4 weeks * Answer the study surveys at baseline and 4 weeks of follow-up
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06597773
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Medicos e Investigadores en la Lucha contra el Cancer de Mama trials
Trials by the same sponsor.
- NCT05837533 — Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer Patients · NA · completed
- NCT05837169 — Randomized Study to Evaluate an Intervention Based on Mindfulness to Reduce Anxiety in Breast Cancer Survivors · NA · completed
- NCT05798312 — Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06597773 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medicos e Investigadores en la Lucha contra el Cancer de Mama
- Last refreshed: 26 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06597773.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing